Nitric oxide synthase activity in brain and endothelium: relation
to hypercapnic rise of cerebral blood flow in rats.
Fabricius, Martin, Inger Rubin, Magnus Bundgaard, and Martin
Lauritzen.
Department of Medical Physiology, University of Copenhagen,
Laboratory of Clinical Neurophysiology, Rigshospitalet, Copenhagen,
Department of Medical Biochemistry, University of Copenhagen,
Department of Clinical Neurophysiology, Glostrup Hospital, Glostrup,
Denmark
APStracts 3:0228H, 1996.
We examined whether attenuation of the hypercapnic increase of
cerebral blood flow (CBF) associated with nitric oxide synthase (NOS)
inhibition was related to local neuronal or aortic endothelial NOS
activity, or local endothelial/neuronal NOS-dependent vasodilation.
Halothane anaesthetized rats were ventilated, and CBF was measured by
laser-Doppler flowmetry over the parietal and cerebellar cortex. I.v.
NG-nitro-L-arginine (L-NNA) (30 mg/kg) inhibited brain and aortic NOS
activity by 67-70%. Topical L-NNA (1mM) inhibited brain NOS activity
by 91-94%, while aortic NOS activity remained constant. In contrast
i.v. L-NNA attenuated the hypercapnic CBF rise much more efficiently
than topical L-NNA. 7-nitroindazole, another NOS inhibitor,
attenuated endothelial and neuronal NOS activity equally well, and
inhibited the hypercapnic CBF increase as effectively as L
-NNA.Topical L-NNA and 7-nitroindazole abolished local eNOS dependent
vasodilation after 15 min, while hypercapnic CBF was only slightly
reduced. L-NNA injected into the tissue abolished nNOS dependent
vasodilation while hypercapnic CBF was unchanged. The findings
suggest that local NOS activity, whether neuronal or endothelial, is
unimportant for the hypercapnic rise of CBF.
Received 19 December 1995; accepted in final form 14 May 1996.
APS Manuscript Number H1185-5.
Article publication pending Am. J. Physiol. (Heart Circ. Physiology).
ISSN 1080-4757 Copyright 1996 The American Physiological Society.
Published in APStracts on 5 June 96